Anti-IL-5 therapy and the airway microbiome in asthma.
A. Sullivan (Cork, Ireland), C. Ward (Newcastle upon Tyne, United Kingdom), D. Casey (Cork, Ireland), D. Flynn (Cork, Ireland), E. Hunt (Cork, Ireland), J. Eustace (Cork, Ireland), P. O' Byrne (Hamilton, Ontario, Canada), B. Plant (Cork, Ireland), J. Macsharry (Cork, Ireland), D. Murphy (Cork, Ireland)
Source: Virtual Congress 2020 – Recent innovations regarding the mechanisms and treatments of asthma
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Sullivan (Cork, Ireland), C. Ward (Newcastle upon Tyne, United Kingdom), D. Casey (Cork, Ireland), D. Flynn (Cork, Ireland), E. Hunt (Cork, Ireland), J. Eustace (Cork, Ireland), P. O' Byrne (Hamilton, Ontario, Canada), B. Plant (Cork, Ireland), J. Macsharry (Cork, Ireland), D. Murphy (Cork, Ireland). Anti-IL-5 therapy and the airway microbiome in asthma.. 5279
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
The impact of anti-IgE treatment on the airway microbiome in asthma. Source: Virtual Congress 2020 – Recent innovations regarding the mechanisms and treatments of asthma Year: 2020
Neuroregulatorial therapy of bronchial asthma Source: Eur Respir J 2002; 20: Suppl. 38, 55s Year: 2002
Same role and same treatment for airway eosinophilia in asthma and COPD? Source: Eur Respir J 2007; 29: 831-833 Year: 2007
The airway microbiota and exacerbations of COPD Source: ERJ Open Res, 6 (3) 00168-2020; 10.1183/23120541.00168-2020 Year: 2020
IL-33 and airway remodelling in paediatric severe therapy resistant asthma Source: Annual Congress 2012 - Severe asthma and developing allergy in childhood Year: 2012
A study to define the microbiome of the asthmatic airway. Source: International Congress 2017 – Clinical points to ponder in asthma Year: 2017
Involvement of airway eosinophilia and airway hyperresponsiveness in management and therapy for COPD> Source: Virtual Congress 2020 – Clinical studies of COPD: combination inhalers and much more Year: 2020
Anti-IgE treatment, airway inflammation and remodelling in severe allergic asthma: current knowledge and future perspectives Source: Eur Respir Rev 2015; 24: 594-601 Year: 2015
Effect of montelukast on excessive airway narrowing in adult asthmatics not on controller therapy Source: Annual Congress 2006 - New developments in the treatment and management of asthma Year: 2006
Effects of budesonide/formoterol maintenance therapy on airway hyperresponsiveness and inflammation in an allergic rat model Source: Eur Respir J 2004; 24: Suppl. 48, 351s Year: 2004
Long-term asthma treatment guided by airway hyperresponsiveness in children: a randomised controlled trial Source: Eur Respir J 2007; 30: 457-466 Year: 2007
Omalizumab therapy reduces asthma exacerbations in children with severe allergic (IgE-mediated) asthma irrespective of lung function at baseline Source: Annual Congress 2009 - Difficult asthma in children: diagnostic and therapeutic challenges Year: 2009
Heterogeneous response of airway eosinophilia to biologics in severe asthma patients Source: Virtual Congress 2021 – Advances in asthma treatment: monoclonal antibodies Year: 2021
The influence of obesity on bronchial hyperresponsiveness, airway and systemic inflammation, lung function and quality of life in patients with asthma Source: Annual Congress 2008 - Asthma: growing understanding of influential factors Year: 2008
Sublingual monomeric allergoid immunotherapy improves airway inflammation, airway hyperresponsiveness and clinical symptoms in allergic rhinitis and asthma Source: Eur Respir J 2006; 28: Suppl. 50, 439s Year: 2006
Changes in symptoms, respiratory function, airway inflammation, and airway hyperresponsiveness over 10 year of inhaled corticosteroid therapy in adult asthma patients Source: International Congress 2015 – New data on established treatments for asthma and COPD Year: 2015
The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics Source: Eur Respir J 2001; 18: 254-261 Year: 2001
The burden of airway hyperresponsiveness on the control of asthma Source: Annual Congress 2011 - Update on monitoring airway diseases Year: 2011
The airway microbiota is significantly altered in asthma patients with airway hyperresponsiveness to mannitol Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases Year: 2015